The annual NF Conference is the most important scholarly NF scientific event in the world, drawing more than 300 participants worldwide across a wide range of scientific disciplines and clinical backgrounds. Attendees are focused on improving outcomes for patients with neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2) and schwannomatosis. The NF Conference is a critical forum for advancing basic, translational, and clinical research in NF and related fields, while fostering collaborations within and beyond the NF community. It is a key venue for attracting and growing new NF investigators.
The Children’s Tumor Foundation is pleased to be a co-sponsor of the first ever International Symposium on RASopathies to be held in Kerala, India, November 27 – 29, 2017. The meeting will convene leading clinicians, researchers and other health care professions from around the globe, to learn of the latest in the management, diagnosis and current and potential therapeutic targets for treatment of the related genetic disorders that make up the RASopathies, including the neurofibromatoses.
Click here for conference overview.